Nanocarriers for delivery of platinum anticancer drugs

作者：Oberoi Hardeep S; Nukolova Natalia V; Kabanov Alexander V^*; Bronich Tatiana K

来源：Advanced Drug Delivery Reviews, 2013, 65(13-14): 1667-1685.

DOI：10.1016/j.addr.2013.09.014

• Platinum drugs
• Drug delivery systems
• Liposome
• Polymer conjugate
• Dendrime
• Nanotube
• Nanoparticle
• Micelle
• Block ionomer complex

Platinum based anticancer drugs have revolutionized cancer chemotherapy, and continue to be in widespread clinical use especially for management of tumors of the ovary, testes, and the head and neck. However, several dose limiting toxicities associated with platinum drug use, partial anti-tumor response in most patients, development of drug resistance, tumor relapse, and many other challenges have severely limited the patient quality of life. These limitations have motivated an extensive research effort towards development of new strategies for improving platinum therapy. Nanocarrier-based delivery of platinum compounds is one such area of intense research effort beginning to provide encouraging preclinical and clinical results and may allow the development of the next generation of platinum chemotherapy. This review highlights current understanding on the pharmacology and limitations of platinum compounds in clinical use, and provides a comprehensive analysis of various platinum-polymer complexes, micelles, dendrimers, liposomes and other nanoparticles currently under investigation for delivery of platinum drugs.

• 出版日期2013-11-30